[Brookings says government is stifling medical marijuana research]Research has shown that some components of marijuana have promise as a treatment for epilepsy and chronic pain. But according to government officials, marijuana again failed an analysis conducted by the U.S. Food and Drug Administration and NIDA. Keeping marijuana at Schedule I continues an outdated, failed approach—leaving patients and marijuana businesses trapped between state and federal laws," Bluemenauer said. The agency will announce one policy change that could increase the amount of research conducted on marijuana, the officials said. The FDA concluded that medical and scientific data do not yet prove that marijuana is safe and effective as a medicine.

Source: Washington Post August 11, 2016 00:54 UTC